Pluri (PLUR) EBITDA (2010 - 2025)
Pluri (PLUR) reported EBITDA of -$6.5 million for Q4 2025, down 31.25% year-over-year from -$9.5 million in Q4 2024, and down 2.46% quarter-over-quarter from -$6.4 million in Q3 2025.
Pluri (PLUR) EBITDA (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of EBITDA data on file, last reported at -$6.5 million in Q4 2025.
- EBITDA for Q4 2025 came in at -$6.5 million, down 31.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$24.9 million (down 14.52% YoY), and the FY2025 annual result was -$22.2 million, changed 0.08% from the prior year.
- EBITDA retreated to -$6.5 million in Q4 2025 per PLUR's latest filing, from -$6.4 million in the prior quarter.
- Over five years, EBITDA peaked at -$5.0 million in Q4 2024 and troughed at -$14.6 million in Q2 2021.
- A 5-year average of -$7.7 million and a median of -$6.6 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2021 and 2022: EBITDA plunged 92.26% in 2021, then soared 39.49% in 2022.
- A 5-year view of EBITDA shows it stood at -$10.8 million in 2021, then jumped by 38.13% to -$6.7 million in 2022, then gained by 21.95% to -$5.2 million in 2023, then advanced by 4.91% to -$5.0 million in 2024, then slumped by 31.25% to -$6.5 million in 2025.
- Business Quant data shows PLUR's EBITDA at -$6.5 million in Q4 2025, -$6.4 million in Q3 2025, and -$6.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -6.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.51 Mn |
| Sep 30, 2025 | -6.35 Mn |
| Jun 30, 2025 | -6.62 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | -4.96 Mn |
| Sep 30, 2024 | -5.20 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -5.53 Mn |
| Dec 31, 2023 | -5.21 Mn |
| Sep 30, 2023 | -5.38 Mn |
| Jun 30, 2023 | -6.54 Mn |
| Mar 31, 2023 | -7.10 Mn |
| Dec 31, 2022 | -6.68 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -8.88 Mn |
| Mar 31, 2022 | -10.48 Mn |
| Dec 31, 2021 | -10.80 Mn |
| Sep 30, 2021 | -11.44 Mn |
| Jun 30, 2021 | -14.59 Mn |
| Mar 31, 2021 | -14.23 Mn |